Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. I. Inhibition by RP-3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in ratsChie Kudo, Fujiro Sendo, Akemi Araki et al.|The Journal of Immunology|1993Cited by 55